Skin cancer is the most common cancer, and melanoma is one of the deadliest cancers. The key to successfully treating this disease begins with promptly detecting it.1
Ask today about DermaSensor™. The first real-time, non-invasive skin cancer evaluation device for all three common skin cancers.
Shine a light on skin cancer: don't let it go unnoticed.
Find a Physician today with a DermaSensor device near you!
SKIN CANCER
is the most common form of cancer1
Have you noticed any lesions like these?
Basal Cell Carcinoma
Usually open sore-like, red patches or shiny bumps
Squamous Cell Carcinoma
Usually bumpy or sore-like skin cancers that are on the surface layers of the skin
Melanoma
Commonly a darkly pigmented skin cancer spot that can occur anywhere on the body
Highly Atypical Nevus
Irregularly shaped and more than one color. May develop into melanoma
If you see any lesions like these on yourself or a loved one, talk to your doctor today!
Watch to learn more about DermaSensor!
• First FDA-cleared automated device designed to detect all three common skin cancers2
• Results in under 30 seconds2
• Harmless and non-invasive2
• DermaSensor can be used on all skin tones2
Choose DermaSensor to give you peace of mind.
Discover peace of mind with DermaSensor! With an impressive 96% sensitivity for detecting all three common skin cancers, you’ll get rapid and immediate results.3
Your skin deserves the best!
DermaSensor can be used on all skin tones
In an FDA pivotal study, DermaSensor was used and validated on more than 1,000 patients across all the Fitzpatrick skin types.4 The Fitzpatrick scale is a skin tone scale developed to classify skin coloring and response to ultraviolet (UV) radiation.
TESTIMONIALS
What are doctors saying about DermaSensor?
“Google said it was cancer but let’s assess your lesion now with our new age AI assisted skin cancer screening device to provide real time objective results”
- Alliance Medical Clinic in Anthem, AZ
"In sunny Miami, skin cancer is a real concern. I’m excited to use a new non-invasive, FDA-cleared, AI-powered device to improve detection accuracy and provide peace of mind for high-risk patients."
- Dr. Eduardo Alacron, Family Medicine
“The DermaSensor device will be a great service to provide to my patients who are concerned about skin lesions, and an invaluable tool to help me decide how to manage their care.”
- Board-certified gynecologist Dr. Dean Hildahl in Naples, Florida
Learn more about DermaSensor. The first real-time, non-invasive skin cancer evaluation device for all three common skin cancers.
1.https://www.skincancer.org/
2.Clinical evidence upon request
3.https://www.dermatologytimes.com/view
/fda-clears-dermasensor-device-for-skin-cancer-detection
80.0300.1
© 2024 DermaSensor, Inc. All Rights Reserved. Please read the Legal Notice for further details.
